Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:50 PM
Ignite Modification Date:
2025-12-24 @ 10:50 PM
NCT ID:
NCT00127569
Eligibility Criteria:
Inclusion Criteria:
* Confirmed multicentric Castleman disease, with dependence on vinblastine or VP16 for at least 3 months, whenever they have been splenectomized
* At least one Castleman crisis since onset of chemotherapy
* Ongoing highly active antiretroviral therapy (HAART) for at least 3 months
* No threshold of CD4 cell count and HIV-RNA
* Signed written informed consent
Exclusion Criteria:
* Prior treatment with rituximab
* Evolutive lymphoma or Kaposi's sarcoma needing treatment
* Absence of effective contraception
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00127569
Study Brief:
Protocol Section:
NCT00127569